Compare Cytokinetics Inc (CYTK) vs Ishares Msci Brazil ETF (EWZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Ishares Msci Brazil ETF — how do they compare? Cytokinetics Inc trades at $81.96 (market cap $11.12B), while Ishares Msci Brazil ETF trades at $36.06. The key difference: Cytokinetics Inc is trading nearer its 52-week high, Ishares Msci Brazil ETF nearer its low. Which is the better fit depends on your goals.
| CYTK | EWZ | |
|---|---|---|
Market Cap | $11.12B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $87.26 | $41.75 |
52-Week Low | $33.23 | $26.52 |
Enterprise Value | $11.59B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $82.24, down 3.1% today, with a bullish technical outlook supported by moving averages and RSI near oversold levels. The company shows strong analyst support with 97% buy ratings and a $110.40 consensus target, but faces fundamental challenges with a -784% net income margin and negative cash flow from operations of -$510M in 2025. Recent positive developments include FDA approval and European launch of Myqorzo, driving commercial momentum.
Outlook remains speculative with high valuation (P/S 93.92) against significant losses, yet growth potential exists if Myqorzo gains market traction. Key risks include cash burn, competitive pressure, and reliance on single drug success. Institutional sentiment is overwhelmingly bullish, but investors must weigh high risk-reward profile amid ongoing profitability challenges.
EWZ, the iShares MSCI Brazil ETF, trades at $35.39, down 1.5% for the day, with a bullish technical signal driven by moving averages. The ETF has gained approximately 11% year-to-date, supported by Brazil's monetary easing cycle and commodity strength. Recent news highlights its exposure to Latin America's equity rally and potential from Brazil's $10 billion Eco Invest auction aimed at sustainable technologies.
The outlook for EWZ is positive, with upside from Brazil's rate cuts and commodity markets, but risks include dependence on volatile commodity prices and potential derailment of the easing cycle. The ETF offers a discounted entry to Brazilian equities, yet payout consistency is a concern due to its concentrated holdings in firms like Petrobras and Vale.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Ishares Msci Brazil ETF
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →
